Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-201722
Filing Date
2018-06-25
Accepted
2018-06-25 07:56:06
Documents
2
Period of Report
2018-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d567024d6k.htm 6-K 15481
2 GRAPHIC g567024g0625131842199.jpg GRAPHIC 8035
  Complete submission text file 0001193125-18-201722.txt   27775
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 18916021
SIC: 2834 Pharmaceutical Preparations